GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cansortium Inc (XCNQ:TIUM.U) » Definitions » Price-to-Free-Cash-Flow

Cansortium (XCNQ:TIUM.U) Price-to-Free-Cash-Flow : 6.96 (As of Sep. 22, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cansortium Price-to-Free-Cash-Flow?

As of today (2024-09-22), Cansortium's share price is $0.16. Cansortium's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.02. Hence, Cansortium's Price-to-Free-Cash-Flow Ratio for today is 6.96.

The historical rank and industry rank for Cansortium's Price-to-Free-Cash-Flow or its related term are showing as below:

XCNQ:TIUM.U' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.69   Med: 4.52   Max: 138.33
Current: 6.96

During the past 6 years, Cansortium's highest Price-to-Free-Cash-Flow Ratio was 138.33. The lowest was 1.69. And the median was 4.52.

XCNQ:TIUM.U's Price-to-Free-Cash-Flow is ranked better than
87.28% of 511 companies
in the Drug Manufacturers industry
Industry Median: 21.66 vs XCNQ:TIUM.U: 6.96

Cansortium's Free Cash Flow per Share for the three months ended in Jun. 2024 was $0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.02.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Cansortium was -39.50% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 80.00% per year.

During the past 6 years, Cansortium's highest 3-Year average Free Cash Flow per Share Growth Rate was 80.00% per year. The lowest was 30.70% per year. And the median was 55.35% per year.


Cansortium Price-to-Free-Cash-Flow Historical Data

The historical data trend for Cansortium's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cansortium Price-to-Free-Cash-Flow Chart

Cansortium Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - 126.67 - 3.00 2.57

Cansortium Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.50 2.09 2.57 6.77 5.65

Competitive Comparison of Cansortium's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Cansortium's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cansortium's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cansortium's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cansortium's Price-to-Free-Cash-Flow falls into.



Cansortium Price-to-Free-Cash-Flow Calculation

Cansortium's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.16/0.023
=6.96

Cansortium's Share Price of today is $0.16.
Cansortium's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Cansortium  (XCNQ:TIUM.U) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Cansortium Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cansortium's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Cansortium Business Description

Traded in Other Exchanges
Address
82 North East 26th Street, Suite 110, Miami, FL, USA, 33137
Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. Its medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.

Cansortium Headlines

No Headlines